NIBEC Co., Ltd. (KOSDAQ: 138610)

Market Cap	161.38B
Revenue (ttm)	19.41B
Net Income (ttm)	-4.84B
Shares Out	10.29M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,080
Open	15,600
Previous Close	15,580
Day's Range	15,600 - 16,090
52-Week Range	14,770 - 25,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 35
• Stock Exchange: KOSDAQ
• Ticker Symbol: 138610

Financial Performance

In 2023, NIBEC's revenue was 15.70 billion, a decrease of -27.53% compared to the previous year's 21.67 billion. Losses were -6.28 billion, 66.9% more than in 2022.